Zoetis (ZTS) Free Cash Flow (QoQ) (2012 - 2026)
Zoetis (ZTS) Free Cash Flow (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.39 Bn | 30.45 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 18.00 Bn | 16.69 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.82% |
| Dec 31, 2025 | -78.21% |
| Sep 30, 2025 | 208.56% |
| Jun 30, 2025 | 21.36% |
| Mar 31, 2025 | -62.80% |
| Dec 31, 2024 | -4.63% |
| Sep 30, 2024 | 48.67% |
| Jun 30, 2024 | 40.44% |
| Mar 31, 2024 | -49.39% |
| Dec 31, 2023 | -18.94% |
| Sep 30, 2023 | 646.31% |
| Jun 30, 2023 | -137.18% |
| Mar 31, 2023 | 241.25% |
| Dec 31, 2022 | -69.58% |
| Sep 30, 2022 | 57.01% |
| Jun 30, 2022 | 9.84% |
| Mar 31, 2022 | -40.31% |
| Dec 31, 2021 | -4.31% |
| Sep 30, 2021 | 81.63% |
| Jun 30, 2021 | -25.94% |